Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK105 vs Paclitaxel in Metastatic Breast Cancer
NCT01644890Phase 3Completed
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Jul 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NK105 in breast cancer, sponsored by Nippon Kayaku Co., Ltd.. Started Jul 2012; status: completed.
02
Drugs
NK105
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01644890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01644890.